Most Read Articles
3 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 4 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, Yesterday

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Self-rated oral health may indicate body weight changes in older people

22 Jun 2020

Self-rated oral health in community-dwelling older adults can help reveal changes in their body weight in the long term, a study has shown. This simple measure may be used to identify a risk for weight loss and to initiate oral interventions in clinical practice.

The investigators analysed prospective data with a 10-year follow-up of 657 Dutch community-dwelling older adults (age, 66.4±5.8 years; 54 percent female) from the Longitudinal Aging Study Amsterdam. They also assessed participants’ characteristics, body weight, and 12 oral health variables (ie, teeth, dentures, nine oral problems, self-rated oral health) in 2005/2007 and 2015/2016.

Mixed models were used to examine the relationship between oral health and body weight, adjusted for demographic, socioeconomic, smoking, health, and functional aspects considering data of both assessments.

Mean body weights were 79.1±13.3 and 77.6±13.8 kg at baseline and follow-up, respectively. At baseline, 29.6 percent of the participants reported being edentulous (follow-up: 34.4 percent) and 55.8 percent were wearing dentures (follow-up: 62.3 percent).

Xerostomia was the oral problem with the highest prevalence at both examinations (baseline: 24.3 percent; follow-up: 30.0 percent), while dental pain while chewing had the lowest prevalence (baseline: 5.2 percent; follow-up: 6.6 percent). Most participants rated their oral status as healthy both at baseline (65.2 percent) and follow-up (66.9 percent).

Edentulism and denture use were not longitudinally associated with body weight, so were oral problems. On the other hand, self-rated oral health correlated with body weight (b=0.724; SE=0.296; p=0.015) after adjusting for confounders.

Knowledge about factors affecting body weight is necessary in order to prevent involuntary weight loss in older people, according to the investigators.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 4 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, Yesterday

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.